Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 18, 2001 09:30 ET | Source: Gene-Cell, Inc.

Gene-Cell Presents Novel Microinjection and Gene Modification Technologies at London Transgenics Conference; Outlines Inventions and Patents Filed for Two Significant Advances in Genetic Medicine

LONDON, Sept. 18, 2001 (PRIMEZONE) -- Brian R. Davis, Ph.D., President and CEO of Gene-Cell, Inc., (OTCBB:GCLL) a leading research and development company devoted to non-viral methods of targeted...